Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1968 Jul 20;3(5611):167–168. doi: 10.1136/bmj.3.5611.167

Mithramycin treatment of malignant hypercalcaemia.

C R Edwards, G M Besser
PMCID: PMC1986142  PMID: 5662551

Full text

PDF
168

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROWN J. H., KENNEDY B. J. MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED TESTICULAR NEOPLASMS. N Engl J Med. 1965 Jan 21;272:111–118. doi: 10.1056/NEJM196501212720301. [DOI] [PubMed] [Google Scholar]
  2. Besser G. M., Butler P. W., Plumpton F. S. Adrenocorticotrophic action of long-acting tetracosactrin compared with corticotrophin-gel. Br Med J. 1967 Nov 18;4(5576):391–394. doi: 10.1136/bmj.4.5576.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Breuer R. I., LeBauer J. Caution in the use of phosphates in the treatment of severe hypercalcemia. J Clin Endocrinol Metab. 1967 May;27(5):695–698. doi: 10.1210/jcem-27-5-695. [DOI] [PubMed] [Google Scholar]
  4. Hebert L. A., Lemann J., Jr, Petersen J. R., Lennon E. J. Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest. 1966 Dec;45(12):1886–1894. doi: 10.1172/JCI105493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. MATTINGLY D. A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Pathol. 1962 Jul;15:374–379. doi: 10.1136/jcp.15.4.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Parsons V., Baum M., Self M. Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease. Br Med J. 1967 Feb 25;1(5538):474–477. doi: 10.1136/bmj.1.5538.474. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES